4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000950170-24-039319
CEO sold 60,000 shares at $33.86 ($2,031,402)
- CEO acquired 77,500 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2024-03-28 | Sale 10b5-1 | −60,000 | $33.86 | $2,031,402 | 998,262 | D |
| Evans John M. CEO | 2024-03-31 | Grant or award 10b5-1 | +77,500 | 1,076,445 | D | ||
| Open-market sales · 60,000 sh · avg $33.86 · $2,031,402 | |||||||
Loading xslF345X05/ownership.xml…